The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
暂无分享,去创建一个
M. Jardine | J. Craig | V. Perkovic | A. Cass | F. Turnbull | J. Chalmers | T. Ninomiya | Anushka Patel | M. Gallagher | R. Huxley | F. Barzi | C. Verdon
[1] B. Astor,et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. , 2007, Archives of internal medicine.
[2] M. Woodward,et al. Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region , 2007, Journal of hypertension.
[3] Rowena J Dolor,et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.
[4] K. Shimamoto,et al. Other health matters to be considered for the Asian population: hypertensive patients at high risk , 2006 .
[5] D. de Zeeuw,et al. Evaluation of measures of urinary albumin excretion. , 2006, American journal of epidemiology.
[6] H. Parving,et al. Microalbuminuria as an early marker for cardiovascular disease. , 2006, Journal of the American Society of Nephrology : JASN.
[7] James R. Madison,et al. Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up: the Honolulu Heart Program. , 2006, Archives of internal medicine.
[8] F. Irie,et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. , 2006, Kidney international.
[9] P. McKeigue,et al. Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: a prospective cohort study. , 2005, Journal of the American Society of Nephrology : JASN.
[10] H Tunstall-Pedoe,et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.
[11] W. Hoy,et al. Albuminuria and incident coronary heart disease in Australian Aboriginal people. , 2005, Kidney international.
[12] S. Haffner,et al. Microalbuminuria as a predictor of myocardial infarction in a Mexican population: the Mexico City Diabetes Study. , 2005, Kidney international. Supplement.
[13] E. Agardh,et al. Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12‐year observation study of 462 patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[14] M. Nieminen,et al. Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study , 2005, Hypertension.
[15] R. Atkins,et al. Chronic kidney disease in the general population. , 2005, Advances in chronic kidney disease.
[16] M. Woodward,et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. , 2005, International journal of epidemiology.
[17] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[18] M. Woodward,et al. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. , 2004, International journal of epidemiology.
[19] K. Borch-Johnsen,et al. Preventive cardiology: abstractVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes☆ , 2004 .
[20] Zhongxin Zhang,et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.
[21] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[22] Constance K Haan,et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[23] N. Day,et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. , 2004, American journal of epidemiology.
[24] N. Chaturvedi,et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. , 2004, Diabetes care.
[25] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.
[26] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[27] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[28] Mark Woodward,et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. , 2003, International journal of epidemiology.
[29] David W Dunstan,et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. , 2003, Journal of the American Society of Nephrology : JASN.
[30] R. Leelawattana,et al. Causes of death, incidence and risk factors of cardiovascular diseases in Thai type 2 diabetic patients: a 5 year follow-up study. , 2003, Diabetes research and clinical practice.
[31] M. Woodward,et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. , 2003, Diabetes care.
[32] G. Eknoyan,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[34] Jiang He,et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.
[35] K. Jablonski,et al. Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study. , 2002, Annals of epidemiology.
[36] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[37] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[38] A. T. N. Group,et al. Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes. , 2001, Diabetologia.
[39] C. Florkowski,et al. Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. , 2001, Diabetes research and clinical practice.
[40] J. Danesh,et al. Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.
[41] D. Levy,et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. , 2000, The American journal of medicine.
[42] S Duval,et al. Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.
[43] R. Klein,et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. , 2000, Archives of internal medicine.
[44] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[45] M. Schroll,et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.
[46] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[47] M. Schroll,et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[48] M. Laakso,et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. , 1999, Circulation.
[49] A. Fitzgerald,et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. , 1998, Diabetes.
[50] M. Laakso,et al. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. , 1996, Stroke.
[51] M. Knuiman,et al. Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. , 1996, Australian and New Zealand journal of medicine.
[52] T. Nakayama,et al. A 15.5-year cohort study on risk factors for possible myocardial infarction and sudden death within 24 hours in a rural Japanese community. , 1996, Journal of epidemiology.
[53] A. Sasaki,et al. Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan. , 1995, Diabetes research and clinical practice.
[54] J. Madans,et al. Proteinuria as a biomarker: risk of subsequent morbidity and mortality. , 1994, Environmental research.
[55] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[56] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[57] B. Scribner,et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.